BrainStorm Announces Resignation of CEO

BrainStorm Cell Therapeutics Inc. (BCLI. OTCBB), a leading developer of adult stem cell technologies and therapeutics, today announced that Abraham (Rami) Efrati, Chief Executive Officer, is resigning from his position at the company in order to pursue other opportunities, effective February 28, 2011.

Be the first to comment

Leave a Reply

Your email address will not be published.